Advanced Manufacturing Late Stage Investors & VC Firms
332 firms in this list, with a median first check of $1.1M. 61 of them lead rounds. Generated from verified public data and updated continuously.
Optimist Ventures
New YorkPre-Seed–Late Stage
4 people
Heartland Ventures
ColumbusPre-Seed–Late Stage$500K – $30M
16 people
Spiltan Invest
StockholmSeed–Late Stage$1.6M – $8.6M
8 people
WONIK Investment Partners
SeoulSeries A–Late Stage
11 people
Braveheart Investment Group
LondonSeed–Late Stage$127K – $1.3M
2 people
The Finnish Innovation Fund Sitra
HelsinkiSeed–Late Stage$108K
2 people
Standard Investments
New YorkSeed–Late Stage
3 people
Lichen Ventures
BaltimoreSeed–Late Stage$200K
1 person
Cornerstone Capital
BeijingSeed–Late Stage
AgriBoom Ventures
Pre-Seed–Late Stage$10K – $4.4M
1 person
ALAMidas Capital Partners
Seed–Late Stage$5M – $50M
1 person
Milkbox Partners
Seed–Late Stage
4 people
Level Eight Ventures
Ann ArborSeed–Late Stage
3 people
Ferd
OsloGrowth–Late Stage$43.2M – $270M
Hotung Investment Holdings Ltd.
SingaporeSeries A–Late Stage$300K – $1.5M
Invest Northern Ireland
BelfastSeed–Late Stage
Peppermint Holding
BerlinSeed–Late Stage
3 people
Firstime Ventures
Tel AvivSeed–Late Stage$500K – $21M
Cemex Ventures
MadridPre-Seed–Late Stage
Darwin Venture Management
TaipeiSeed–Late Stage$1M – $76M
Hony Capital Ltd.
Hong KongGrowth–Late Stage$6M
6 people
IRDI SORIDEC Gestion
ToulouseSeed–Late Stage$216K – $16.2M
Jaws Ventures
Miami BeachSeed–Late Stage
3 people
ONCAP
TorontoGrowth–Late Stage$20M – $250M
Related lists
Late Stage Investors & VC Firms (2864)Advanced Manufacturing Investors & VC Firms (1271)Late Stage Investors & VC Firms in United States (1101)Late Stage Investors & VC Firms in Global (857)Advanced Manufacturing Seed Investors & VC Firms (853)Healthtech Late Stage Investors & VC Firms (847)Enterprise Software Late Stage Investors & VC Firms (801)SaaS Late Stage Investors & VC Firms (784)Advanced Manufacturing Series A Investors & VC Firms (741)Fintech Late Stage Investors & VC Firms (656)
Data sourced from public filings and firms' own websites — see our methodology.






















